Founders Fund VII Management, LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed February 14, 2025), Founders Fund VII Management, LLC reported 1 stock position worth $1.8 million. Its top holding was Compass Pathways (CMPS) at 100.0% of the portfolio. Compared with Q2 2024, it sold out of 1. The biggest sale was an exit from Abcellera Biologics (ABCL).

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001846021
Portfolio Value
$1.8M (Q3 2024)
SEC Filing
0001085146-25-001680 ↗ filed Feb 14, 2025

Holdings Value

0$5.0M$10.0M$15.0M$20.0M Q1 2024: $19.4M Q1 2024 Q2 2024: $12.9M Q2 2024 Q3 2024: $1.8M $1.8M Q3 2024 Q4 2024: $1.1M Q4 2024 Q1 2025: $798K Q1 2025 Q2 2025: $781K Q2 2025 Q3 2025: $1.7M Q3 2025 Q4 2025: $2.0M Q4 2025

Holdings 1 stocks · $1.8M

CMPS Compass Pathways PLC 100.00% 278,880 $1.8M No change

Portfolio Sells Q2 2024 → Q3 2024

ABCL Abcellera Biologics Inc. Sold out 0.00% −86.90

Portfolio Buys Q2 2024 → Q3 2024

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 2$2.0MCMPS, RUM
Q3 2025 2$1.7MCMPS, RUM
Q2 2025 1$781KCMPS
Q1 2025 1$798KCMPS
Q4 2024 1$1.1MCMPS
Q3 2024Amended 1$1.8MCMPS
Q2 2024 2$12.9MABCL, CMPS
Q1 2024 2$19.4MABCL, CMPS